Posttransplant diabetes mellitus in cyclosporine-treated renal allograft patients:: A case-control study

被引：4

作者：

Copstein, LA

Zelmanovitz, T

Gonçalves, LF

Manfro, RC

机构：

[1] Hosp Clin Porto Alegere, Div Nephrol, BR-90035003 Porto Alegre, RS, Brazil

[2] Univ Fed Rio Grande do Sul, Nephrol Post Graduat Program, Sch Med, BR-90035003 Porto Alegre, RS, Brazil

来源：

TRANSPLANTATION PROCEEDINGS | 2004年 / 36卷 / 04期

关键词：

D O I：

10.1016/j.transproceed.2004.04.008

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The incidence and risk factors for the development of posttransplant diabetes mellitus (PTDM) was retrospectively evaluated in cyclosporine-treated renal transplant patients. An incidence of 9.4% was observed over a 10-year period. Weight and body mass index were risk factors identified in a case-controlled study. Age, race, family history of DM, and cyclosporine and prednisone doses were not associated with the development of PTDM. We concluded that the development of PTDM is mainly related to weight. All efforts must be taken to avoid this complication.

引用

页码：882 / 883

页数：2

共 6 条

[1] Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: Results at 2 years [J].